TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pharmex AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
24,793
|
22,673
|
17,151 |
| Financial expenses |
765
|
827
|
97 |
| Earnings before taxes |
3,614
|
3,338
|
2,335 |
| Total assets |
10,926
|
9,224
|
9,109 |
| Current assets |
10,926
|
9,224
|
9,109 |
| Current liabilities |
3,812
|
2,864
|
3,751 |
| Equity capital |
6,897
|
6,078
|
4,975 |
| - share capital |
601
|
601
|
601 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
63.1%
|
65.9%
|
54.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
14.6%
|
14.7%
|
13.6% |
| Return on assets (ROA) |
40.1%
|
45.2%
|
26.7% |
| Current ratio |
286.6%
|
322.1%
|
242.8% |
| Return on equity (ROE) |
52.4%
|
54.9%
|
46.9% |
| Change turnover |
2,120
|
5,522
|
3,709 |
| Change turnover % |
9%
|
32%
|
28% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.